Literature DB >> 16010573

Inhibition of sortase-mediated Staphylococcus aureus adhesion to fibronectin via fibronectin-binding protein by sortase inhibitors.

Ki-Bong Oh1, Mi-Na Oh, Jae-Gyu Kim, Dong-Sun Shin, Jongheon Shin.   

Abstract

The sortase enzymes are a family of Gram-positive transpeptidases responsible for anchoring surface protein virulence factors to the peptidoglycan cell wall layer. In Staphylococcus aureus, deletion of the sortase isoforms results in marked reduction in virulence and infection potential, making it an important antivirulence target. Recombinant sortase A (SrtA) and sortase B (SrtB) were incubated with peptide substrate containing either the LPETG or NPQTN motifs. (Z)-3-(2,5-dimethoxyphenyl)-2-(4-methoxyphenyl) acrylonitrile, beta-sitosterol-3-O-glucopyranoside, berberine chloride, and psammaplin A1 showed potent inhibitory activity against SrtA and SrtB. These compounds also exhibited potent inhibitory activity against S. aureus cell adhesion to fibronectin. The fibronectin-binding activity data highlight the potential of these compounds for the treatment of S. aureus infections via inhibition of sortase activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16010573     DOI: 10.1007/s00253-005-0040-8

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  29 in total

Review 1.  Sortases and the art of anchoring proteins to the envelopes of gram-positive bacteria.

Authors:  Luciano A Marraffini; Andrea C Dedent; Olaf Schneewind
Journal:  Microbiol Mol Biol Rev       Date:  2006-03       Impact factor: 11.056

Review 2.  Sortase transpeptidases: insights into mechanism, substrate specificity, and inhibition.

Authors:  Kathleen W Clancy; Jeffrey A Melvin; Dewey G McCafferty
Journal:  Biopolymers       Date:  2010       Impact factor: 2.505

Review 3.  Pharmacological Targeting of the Host-Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs.

Authors:  Jason Munguia; Victor Nizet
Journal:  Trends Pharmacol Sci       Date:  2017-03-08       Impact factor: 14.819

4.  Comparison of the Effects of Myrtus Communis L, Berberis Vulgaris and Metronidazole Vaginal Gel alone for the Treatment of Bacterial Vaginosis.

Authors:  Mansoureh Masoudi; Sepideh Miraj; Mahmoud Rafieian-Kopaei
Journal:  J Clin Diagn Res       Date:  2016-03-01

5.  Novel Benzimidazole Inhibitors of Botulinum Neurotoxin/A Display Enzyme and Cell-Based Potency.

Authors:  Steven C Cardinale; Michelle M Butler; Gordon Ruthel; Jonathan E Nuss; Laura M Wanner; Bing Li; Ramdas Pai; Norton P Peet; Sina Bavari; Terry L Bowlin
Journal:  Botulinum J       Date:  2011

6.  Probing of the cis-5-phenyl proline scaffold as a platform for the synthesis of mechanism-based inhibitors of the Staphylococcus aureus sortase SrtA isoform.

Authors:  Konstantin V Kudryavtsev; Matthew L Bentley; Dewey G McCafferty
Journal:  Bioorg Med Chem       Date:  2009-02-13       Impact factor: 3.641

7.  Inactivation of sortase A mediated by metal ATCUN complexes.

Authors:  Insiya Fidai; Lalintip Hocharoen; Seth Bradford; Christine Wachnowsky; J A Cowan
Journal:  J Biol Inorg Chem       Date:  2014-09-09       Impact factor: 3.358

8.  Impact of Lactobacillus plantarum sortase on target protein sorting, gastrointestinal persistence, and host immune response modulation.

Authors:  Daniela M Remus; Roger S Bongers; Marjolein Meijerink; Fabrizia Fusetti; Bert Poolman; Paul de Vos; Jerry M Wells; Michiel Kleerebezem; Peter A Bron
Journal:  J Bacteriol       Date:  2012-11-21       Impact factor: 3.490

9.  Antiinfective therapy with a small molecule inhibitor of Staphylococcus aureus sortase.

Authors:  Jie Zhang; Hongchuan Liu; Kongkai Zhu; Shouzhe Gong; Shaynoor Dramsi; Ya-Ting Wang; Jiafei Li; Feifei Chen; Ruihan Zhang; Lu Zhou; Lefu Lan; Hualiang Jiang; Olaf Schneewind; Cheng Luo; Cai-Guang Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-02       Impact factor: 11.205

Review 10.  Targeting Bacterial Sortases in Search of Anti-Virulence Therapies with Low Risk of Resistance Development.

Authors:  Georgiana Nitulescu; Denisa Margina; Anca Zanfirescu; Octavian Tudorel Olaru; George Mihai Nitulescu
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.